<turbo-stream action="append" target="news"><template>  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positiv
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/CRISPR-Therapeutics-AG-CH0334081137">CRISPR Therapeutics AG</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">The Motley Fool</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 5 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.fool.com/investing/2026/04/21/crispr-therapeutics-has-major-catalysts-ahead-is-t/">CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy?</a>
    </div>

      <div class="me-0 me-md-5">
        CRISPR Therapeutics plans to post clinical trial updates for multiple candidates this year. The company&#39;s stock could jump if it can impress the market.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positiv
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/CRISPR-Therapeutics-AG-CH0334081137">CRISPR Therapeutics AG</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">The Motley Fool</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 5 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.fool.com/investing/2026/04/13/2-billion-reasons-to-love-crispr-therapeutics-now/">2 Billion Reasons to Love CRISPR Therapeutics Right Now</a>
    </div>

      <div class="me-0 me-md-5">
        CRISPR Therapeutics is still losing money, but it has an expanding pipeline. The biotech is seeing growing sales from its one product, Casgevy.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positiv
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/CRISPR-Therapeutics-AG-CH0334081137">CRISPR Therapeutics AG</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">The Motley Fool</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 5 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.fool.com/investing/2026/04/08/this-biotech-has-a-pipeline-that-could-redefine-it/">This Biotech Has a Pipeline That Could Redefine Its Entire Therapeutic Area</a>
    </div>

      <div class="me-0 me-md-5">
        CRISPR Therapeutics has a pair of candidates that could transform how we address certain risk factors for cardiovascular conditions. They aren&#39;t the only promising candidates in the pipeline, either.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/CRISPR-Therapeutics-AG-CH0334081137">CRISPR Therapeutics AG</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">GlobeNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 5 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.globenewswire.com/news-release/2026/04/07/3269071/0/en/CRISPR-Therapeutics-to-Present-at-the-25th-Annual-Needham-Virtual-Healthcare-Conference.html">CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference</a>
    </div>

      <div class="me-0 me-md-5">
        ZUG, Switzerland and BOSTON, April 07, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, Apr 13 at 2:15 p.m. ET. A live webcast of the fireside chat will be available on the &quot;Events &amp; Presentations&quot; page in the Investors section of the Company&#39;s w...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positiv
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/CRISPR-Therapeutics-AG-CH0334081137">CRISPR Therapeutics AG</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">The Motley Fool</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 5 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.fool.com/investing/2026/04/07/is-this-biotech-stock-your-best-shot-at-building-a/">Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position?</a>
    </div>

      <div class="me-0 me-md-5">
        CRISPR Therapeutics is the second largest holding in Cathie Wood&#39;s Ark Innovation ETF. Incoming clinical trial data could send the stock soaring this year.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positiv
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/CRISPR-Therapeutics-AG-CH0334081137">CRISPR Therapeutics AG</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">24/7 Wall Street</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 6 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://247wallst.com/investing/2026/04/03/the-personalized-biotech-flywheel-cathie-wood-built-is-still-a-winning-bet-today/?utm_source=snapi">The Personalized Biotech Flywheel Cathie Wood Built Is Still a Winning Bet Today</a>
    </div>

      <div class="me-0 me-md-5">
        What if the biggest winners in biotech weren&#39;t the ones promising miracle cures, but the ones quietly supplying the picks and shovels — data that makes those cures possible?
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/CRISPR-Therapeutics-AG-CH0334081137">CRISPR Therapeutics AG</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">The Motley Fool</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 6 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.fool.com/investing/2026/03/23/crispr-therapeutics-stock-is-it-a-bargain-buy-righ/">CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?</a>
    </div>

      <div class="me-0 me-md-5">
        CRISPR recently raised nearly $600 million through a private offering, which weighed down its share price. The company has an approved therapy in Casgevy, but its business remains deeply unprofitable.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positiv
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/CRISPR-Therapeutics-AG-CH0334081137">CRISPR Therapeutics AG</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">The Motley Fool</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 6 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.fool.com/investing/2026/03/20/is-crispr-therapeutics-stock-a-buy-now/">Is CRISPR Therapeutics Stock a Buy Now?</a>
    </div>

      <div class="me-0 me-md-5">
        CRISPR Therapeutics&#39; lone approved product isn&#39;t generating much revenue yet. The company has made little clinical progress elsewhere in recent years.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

</template></turbo-stream><turbo-stream action="replace" target="link"><template><div id="link">
    <a class="btn btn-outline-primary btn--small" data-turbo-stream="" href="/news/CRISPR-Therapeutics-AG-CH0334081137/load_more?page=3">
      Mehr Neuigkeiten anzeigen
      <i class="fa fa-arrow-down fa-fw"></i>
</a></div>
</template></turbo-stream>